<DOC>
	<DOCNO>NCT00437853</DOCNO>
	<brief_summary>EFFICACY OF NEOADJUVANT ENDOCRINE THERAPY WITH ANASTROZOLE IN POMENOPAUSAL WOMEN WITH ER-POSITIVE BREAST CANCER . Flavia Morales-Vásquez , Horacio Noé López Basave . Background : Neoadjuvant Hormonal Therapy ( HT ) use increasingly downstage locally advanced large operable breast cancer . Following treatment , inoperable breast cancer often become fully respectable tumor require mastectomy may successfully remove breast-conserving surgery ( BCS ) . Methods : Recruit postmenopausal woman ER ( + ) and/or PgR ( + ) breast cancer ( BC ) T2 , N1-2 T3 , N0-1 assign HT anastrozole 1 mgr daily 4 month . The primary endpoint compare overall objective response ( OR ) determine clinical ( palpation ) ultrasound . Secondary endpoint number patient qualify BCS plus radiotherapy .</brief_summary>
	<brief_title>Neoadjuvant Hormonal Treatment Postmenopausal Women Who Have Operable Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Postmenopausal woman primary breast cancer , histological confirm , core needle biopsy , { tumor positive estrogen receptor ER/PR . Clinical stage IIB IIIA Tumor assessable clinical exam , mammogram ultrasound Adequate functional bone marrow Documented evidence adequate renal function liver function Life expectancy six month Written inform consent Prior treatment letrozole tamoxifen uncontrol disorder patient instable angina uncontrol cardiac disease patient bilateral breast tumor patient elegy conservative breast surgery Inflammatory breast cancer distant metastases Other concurrent malignancy , except carcinoma situ cono biopsy uterine cervix adequate treat skin cancer melanoma concomitant cancer treatment chemotherapy , immunotherapy biological modulators , endocrinotherapy , biphosphonates therapy radiotherapy . Concomitant treatment steroid Others research drug white last 30 day concomitant use research drug History non compliance medication schedule patient consider potential unreliable .</criteria>
	<gender>Female</gender>
	<minimum_age>66 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>